Home Newsfeeds BTIG Upgrades Borr Drilling to Buy

BTIG Upgrades Borr Drilling to Buy

BTIG analyst Gregory Lewis upgrades Borr Drilling (NYSE:BORR) from Neutral to Buy.

byBenzinga Newsdesk

January 6, 2023

1 minute read

BTIG analyst Gregory Lewis upgrades Borr Drilling (NYSE:BORR) from Neutral to Buy.

Analyst Ratings

What 9 Analyst Ratings Have To Say About Roivant Sciences

By Benzinga Insights

August 31, 12:00 PM

Over the past 3 months, 9 analysts have published their opinion on Roivant Sciences (NASDAQ:ROIV) stock. These analysts…

ROIV

WWE Could Be A Netflix Game Changer, Capitalizing On ‘Opportunities To Maximize Fan Growth And Engagement’

By Chris Katje

April 8, 12:02 PM

A partnership with Netflix and continued strength of live events and sponsorship opportunities could be catalysts for WWE parent TKO Group Holdings.

$TKO

Dyne Therapeutics Presents Preclinical Data From Its Duchenne Muscular Dystrophy Programs Targeting Exons 51 and 53 At World Muscle Society 2022 Congress October 11-15

By Benzinga Newsdesk

October 11, 4:26 PM

- Poster Highlights In Vivo Data for DYNE-251, Now Being Evaluated in Phase 1/2 DELIVER Clinical Trial in Patients Amenable to Exon 51 Skipping - - First Presentation of In Vitro Data for FORCE™ Platform

DYN

Arvinas, Pfizer Plan To Broaden Development Of Breast Cancer Candidate

By Vandana Singh

December 6, 9:50 AM

Arvinas Inc (NASDAQ: ARVN) and Pfizer Inc (NYSE: PFE) released clinical data for vepdegestrant (ARV-471) in combination with

ARVN

BTIG Upgrades Borr Drilling to Buy

Related Posts

What 9 Analyst Ratings Have To Say About Roivant Sciences

WWE Could Be A Netflix Game Changer, Capitalizing On ‘Opportunities To Maximize Fan Growth And Engagement’

Dyne Therapeutics Presents Preclinical Data From Its Duchenne Muscular Dystrophy Programs Targeting Exons 51 and 53 At World Muscle Society 2022 Congress October 11-15

Arvinas, Pfizer Plan To Broaden Development Of Breast Cancer Candidate